Company Lifecore Biomedical, Inc.

Equities

LFCR

US5147661046

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
6.595 USD -0.68% Intraday chart for Lifecore Biomedical, Inc. -1.42% +6.54%

Business Summary

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Number of employees: 459

Sales per Business

USD in Million2022Weight2023Weight Delta
Lifecore
100.0 %
109 58.8 % 103 100.0 % -5.54%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
146 78.5 % 103 100.0 % -29.27%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 17-05-31
Director of Finance/CFO 60 21-01-17
Chief Operating Officer - 19-12-31
Chief Tech/Sci/R&D Officer - 22-04-30
Chief Tech/Sci/R&D Officer 69 09-12-31
Corporate Officer/Principal - 10-05-31
Human Resources Officer - 21-09-30
Corporate Officer/Principal - 21-10-31
Corporate Officer/Principal - 17-04-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 77 18-10-11
Director/Board Member 64 20-10-13
Director/Board Member 66 19-08-04
Director/Board Member 51 20-10-13
Director/Board Member 66 22-01-19
Chief Executive Officer 61 17-05-31
Director/Board Member 53 23-01-08
Chairman 57 19-10-15
Director/Board Member 42 23-01-08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 30,546,936 29,162,611 ( 95.47 %) 0 95.35 %
Stock B 0 39,000 0 0

Shareholders

NameEquities%Valuation
Wynnefield Capital, Inc.
16.12 %
4,923,545 16.12 % 26 M $
Legion Partners Asset Management LLC
9.626 %
2,940,340 9.626 % 16 M $
Greenhaven Road Investment Management LP
7.749 %
2,366,956 7.749 % 13 M $
22NW LP
5.746 %
1,755,161 5.746 % 9 M $
22NW LP
5.746 %
1,755,161 5.746 % 9 M $
Vanguard Global Advisers LLC
4.421 %
1,350,567 4.421 % 7 M $
325 Capital LLC
3.951 %
1,206,969 3.951 % 6 M $
Cove Street Capital LLC
2.980 %
910,264 2.980 % 5 M $
Morgan Stanley Capital Services LLC
2.582 %
788,702 2.582 % 4 M $
BlackRock Institutional Trust Co. NA
1.690 %
516,243 1.690 % 3 M $
NameEquities%Valuation
22NW LP
41.64 %
16,134 41.64 % 85 672 $
Legion Partners Asset Management LLC
25.51 %
9,887 25.51 % 52 500 $
Wynnefield Capital, Inc.
8.387 %
3,250 8.387 % 17 258 $
Cove Street Capital LLC
7.871 %
3,050 7.871 % 16 196 $

Company contact information

Lifecore Biomedical, Inc.

3515 Lyman Boulevard

55318, Chaska

+952 368 4300

http://www.lifecore.com
address Lifecore Biomedical, Inc.(LFCR)

Group companies

NameCategory and Sector
Food Distributors
Food: Major Diversified

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.595 USD
Average target price
6 USD
Spread / Average Target
-9.02%
Consensus
  1. Stock Market
  2. Equities
  3. LFCR Stock
  4. Company Lifecore Biomedical, Inc.